HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients

Ebrahimi, Samaneh; Reza Ghasemi-Basir, Hamid; Mahdi Majzoobi, Mohammad; Rasouli-Saravani, Ashkan; Hajilooi, Mehrdad; Solgi, Ghasem

Human leukocyte antigen (HLA) genes with extreme diversity can make a contribution for individual variations to the immune response against SARS-COV-2 infection. This study aimed to explore the distributions of HLA class II alleles frequencies and their relations with disease severity in a group of Iranian COVID-19 patients. This prospective and case-control study was conducted on 144 COVID-19 patients including 46 cases with moderate form, 54 cases with severe and 44 cases with critical disease. HLA-DRB1 and –DQB1 allele families were determined by PCR-SSP method and compared between three groups of the patients and in comparison to 153 ethnic-matched healthy controls. The patients group showed lower frequencies of HLA-DRB1*15 (OR=0.57, P=0.06), DRB1*15∼DQB1*05 haplotype (P=0.04) and DRB1*15/DRB1*04 genotype (P=0.04) in compare with healthy controls. Moderate COVID-19 patients had higher frequencies of HLA-DRB1*04 (P=0.03), HLA-DRB1*10 (P=0.05) and DRB1*04/DRB1*11 genotype (P=0.01). Also, a higher significantly frequency of HLA-DRB1*03 allele group was observed in the critical patients versus controls (P=0.01). Multiple logistic regression analysis revealed that the presence of DRB1*04 allele group was negatively associated with development of severe and critical disease (OR: 0.289, P=0.005). Our results indicate a possible contribution of some HLA class II alleles in disease severity and clinical features of COVID-19 disease.